Trial intelligence / Profile preview

Safety and Efficacy of RTS,S/AS02D Malaria Vaccine in Infants in Mozambique

NCT00197028Phase 2Completed

Sponsor
GSK
Start
Aug 2005
Primary completion
Dec 2007
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of RTS,S in malaria, sponsored by GSK. Started Aug 2005; status: completed.

02

Drugs

RTS,S
03

Conditions

malaria

Beyond the preview

Go deeper on NCT00197028.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00197028.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call